Toxicity of antiseptics against chondrocytes: what is best for the cartilage in septic joint surgery?
In septic joint surgery, the most frequently used antiseptics are polyhexanide, hydrogen peroxide and taurolidine. The aim of this study was to examine the effects of these antiseptics on viability of human chondrocytes. Our hypothesis was that antiseptics and supplemental irrigation with sodium chloride lavage are less toxic on human chondrocytes than treatment with antiseptics only. Primary human chondrocytes were isolated and cultured from six donated human knee joints. Polyhexanide, hydrogen peroxide or taurolidine were added to the cultures. Toxicity analysis was performed by visualisation of cell structure using light microscopy and LDH activity. The determination of vital cells and total cell numbers of chondrocytes treated with antiseptics partly followed by irrigation with sodium chloride solution was performed by using Casy Cell-Counter. Light microscopic data revealed a defect in cell structure after addition of antiseptics. We showed a significant increase of LDH enzyme activity after the treatment with polyhexanide or taurolidine. After treatment with antiseptics followed by sodium chloride solution a significant increase of vital and total cell numbers resulted in comparison with the chondrocytes that were only treated with antiseptics. The data show that treatment with polyhexanid, hydrogen peroxide or taurolidine induces cell death of human chondroctes in vitro. The application of sodium chloride solution after the treatment with polyhexanide and hydrogen peroxide possibly has a protective effect on chondrocyte viability.
Department of Traumatology and Orthopaedics, Charité - Universitätsmedizin, Berlin, Germany. eric.roehner@charite.de
Eric
E
Röhner
Paula
P
Kolar
Joern B
JB
Seeger
Joerg
J
Arnholdt
Kathi
K
Thiele
Carsten
C
Perka
Georg
G
Matziolis
D000891:Anti-Infective Agents, Local / Q000633:toxicity*; D001170:Arthritis, Infectious / Q000188:drug therapy* / Q000382:microbiology / Q000601:surgery; D001645:Biguanides / Q000633:toxicity*; D002358:Cartilage, Articular / Q000187:drug effects* / Q000473:pathology; D002452:Cell Count; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D019902:Chondrocytes / Q000187:drug effects* / Q000201:enzymology / Q000473:pathology; D006801:Humans; D006861:Hydrogen Peroxide / Q000633:toxicity*; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D020370:Osteoarthritis, Knee / Q000601:surgery; D013654:Taurine / Q000031:analogs & derivatives* / Q000633:toxicity; D007507:Therapeutic Irrigation; D013829:Thiadiazines / Q000633:toxicity*
D000891:Anti-Infective Agents, Local; D001645:Biguanides; D013829:Thiadiazines; D013654:Taurine; C031233:polihexanide; C012566:taurolidine; D006861:Hydrogen Peroxide; D007770:L-Lactate Dehydrogenase
Methods Achiev Exp Pathol. 1988;13:18-54
3045494
Arthroscopy. 1986;2(1):30-4
3485436
Swiss Med Wkly. 2007 Mar 10;137(9-10):139-45
17370154
Calcif Tissue Int. 2010 Oct;87(4):333-40
20582408
Unfallchirurg. 2001 Aug;104(8):682-6
11569148
Int Wound J. 2009 Dec;6(6):420-30
20051094
Eplasty. 2010 May 27;10:e39
20526354
Scand J Rheumatol. 1989;18(1):7-12
2649978
Z Orthop Ihre Grenzgeb. 2003 Mar-Apr;141(2):233-8
12695963
Arthroscopy. 1992;8(2):213-23
1637435
Dtsch Med Wochenschr. 1997 Feb 7;122(6):167-8
9081803
Z Orthop Unfall. 2010 Jan;148(1):39-43
20135588
J Orthop Res. 2004 Sep;22(5):1120-5
15304288
Clin Rheumatol. 2003 Dec;22(6):386-90
14677011
Acta Orthop Scand. 1987 Feb;58(1):14-9
3577735
Br J Rheumatol. 1997 Mar;36(3):370-3
9133971